Aarti Pharmalabs Limited Share Price & Analysis
₹702.35▲ +0.63%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹702.35
+0.63%
Open
₹—
High
₹707.8
Low
₹695.8
Close
₹702.35
52W High
₹970
52W Low
₹584
Volume
83K
Lot Size
1
Sector
Healthcare
Market Cap
₹6K Cr
Face Value
₹5
Mid Cap
Price Chart
Fundamentals
P/E
36.3
Sector P/E
54.4
P/B
3
EPS
₹23.58
ROE
8.59%
ROCE
10.7%
D/E Ratio
0.35
Div Yield
0.71%
Book Value
₹234
+
Strengths
- ✓Attractively valued vs sector (P/E 36.3x vs industry 54.4x)
- ✓Low debt relative to equity (D/E 0.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AARTIPHARM · as of Mar 2026
Promoters44.29%▼0.36
FII7.36%▼1.28
DII7.53%▼2.83
Public40.81%▲4.48
Govt0.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 46.46% | 46.46% | 46.46% | 46.10% | 44.65% | 44.29% |
| FII | 8.17% | 8.33% | 7.07% | 7.38% | 8.64% | 7.36% |
| DII | 9.91% | 9.97% | 11.47% | 11.35% | 10.36% | 7.53% |
| Public | 35.45% | 35.24% | 35.00% | 35.17% | 36.33% | 40.81% |
| Govt | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Corporate Events
AARTIPHARM : 25-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 18, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held
Dividend24 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend17 May 2026
Interim Dividend - Rs 1.50 Per Share
Dividend15 Feb 2026
Dividend - Rs 2.50 Per Share
Dividend14 Sept 2025
Interim Dividend - Rs 2.50 Per Share
Dividend13 Feb 2025
Dividend - Re 1 Per Share
Dividend30 Jul 2024
Interim Dividend - Rs 2 Per Share
Record: 18 Feb 2024
Dividend15 Feb 2024
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹432 Cr ▲3.3% | ₹418 Cr ▲8.3% | ₹386 Cr ▼31.6% | ₹564 Cr ▲4.8% | ₹538 Cr ▲17.5% | ₹458 Cr ▼17.5% | ₹555 Cr ▲9.7% | ₹506 Cr |
| Op. Profit | ₹102 Cr ▲37.8% | ₹74 Cr ▼20.4% | ₹93 Cr ▼36.3% | ₹146 Cr ▲13.2% | ₹129 Cr ▲37.2% | ₹94 Cr ▼2.1% | ₹96 Cr ▼18.6% | ₹118 Cr |
| OPM | 24.0% ▲33.3% | 18.0% ▼25.0% | 24.0% ▼7.7% | 26.0% ▲8.3% | 24.0% ▲20.0% | 20.0% ▲17.6% | 17.0% ▼26.1% | 23.0% |
| Net Profit | ₹48 Cr ▲71.4% | ₹28 Cr ▼44.0% | ₹50 Cr ▼43.2% | ₹88 Cr ▲18.9% | ₹74 Cr ▲34.5% | ₹55 Cr ▲0.0% | ₹55 Cr ▼15.4% | ₹65 Cr |
| EPS (₹) | 5.29 ▲71.8% | 3.08 ▼43.6% | 5.46 ▼44.0% | 9.75 ▲19.5% | 8.16 ▲35.3% | 6.03 ▼1.5% | 6.12 ▼15.0% | 7.2 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹1.8K Cr ▼14.0% | ₹2.1K Cr ▲14.1% | ₹1.9K Cr ▼4.7% | ₹1.9K Cr ▲62.1% | ₹1.2K Cr | ₹0 Cr |
| Expenses | ₹1.4K Cr ▼12.2% | ₹1.7K Cr ▲12.5% | ₹1.5K Cr ▼8.5% | ₹1.6K Cr ▲61.4% | ₹993 Cr | ₹0 Cr |
| Op. Profit | ₹369 Cr ▼20.5% | ₹464 Cr ▲20.2% | ₹386 Cr ▲12.9% | ₹342 Cr ▲65.2% | ₹207 Cr | ₹0 Cr |
| OPM | 20.0% ▼9.1% | 22.0% ▲4.8% | 21.0% ▲16.7% | 18.0% ▲5.9% | 17.0% | — |
| Other Income | ₹15 Cr ▲50.0% | ₹10 Cr ▲100.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▼33.3% | ₹3 Cr | ₹0 Cr |
| Interest | ₹47 Cr ▲74.1% | ₹27 Cr ▲58.8% | ₹17 Cr ▼19.0% | ₹21 Cr ▲75.0% | ₹12 Cr | ₹0 Cr |
| Depreciation | ₹104 Cr ▲19.5% | ₹87 Cr ▲19.2% | ₹73 Cr ▲15.9% | ₹63 Cr ▲50.0% | ₹42 Cr | ₹0 Cr |
| PBT | ₹233 Cr ▼35.5% | ₹361 Cr ▲20.3% | ₹300 Cr ▲14.9% | ₹261 Cr ▲68.4% | ₹155 Cr | ₹0 Cr |
| Tax % | 25.0% ▲4.2% | 24.0% ▼14.3% | 28.0% ▲7.7% | 26.0% ▲23.8% | 21.0% | — |
| Net Profit | ₹175 Cr ▼35.7% | ₹272 Cr ▲25.3% | ₹217 Cr ▲12.4% | ₹193 Cr ▲58.2% | ₹122 Cr | ₹0 Cr |
| EPS (₹) | 19.27 ▼35.9% | 30.05 ▲25.6% | 23.93 ▲12.1% | 21.35 | — | — |
| Div Payout | 18.0% ▲5.9% | 17.0% ▲30.8% | 13.0% ▲44.4% | 9.0% | 0.0% | — |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Liabilities | |||||||
| Equity Capital | ₹45 Cr ▲0.0% | ₹45 Cr ▲0.0% | ₹45 Cr ▲0.0% | ₹45 Cr ▲0.0% | ₹45 Cr ▲17900.0% | ₹0.25 Cr ▲0.0% | ₹0.25 Cr |
| Reserves | ₹2.1K Cr ▲3.9% | ₹2.0K Cr ▲2.9% | ₹1.9K Cr ▲13.6% | ₹1.7K Cr ▲13.2% | ₹1.5K Cr ▲9.2% | ₹1.4K Cr | ₹0 Cr |
| Borrowings | ₹754 Cr ▲14.4% | ₹659 Cr ▲59.6% | ₹413 Cr ▲44.9% | ₹285 Cr ▲32.6% | ₹215 Cr ▼36.4% | ₹338 Cr | ₹0 Cr |
| Other Liabilities | ₹603 Cr ▲7.5% | ₹561 Cr ▲11.5% | ₹503 Cr ▼6.9% | ₹540 Cr ▲14.9% | ₹470 Cr ▲49.2% | ₹315 Cr | ₹0 Cr |
| Total Liabilities | ₹3.5K Cr ▲6.6% | ₹3.3K Cr ▲12.4% | ₹2.9K Cr ▲12.5% | ₹2.6K Cr ▲15.1% | ₹2.2K Cr ▲10.0% | ₹2.0K Cr | ₹0 Cr |
| Assets | |||||||
| Fixed Assets | ₹1.5K Cr ▲0.7% | ₹1.5K Cr ▲33.2% | ₹1.1K Cr ▲10.1% | ₹1.0K Cr ▲11.6% | ₹926 Cr ▲18.4% | ₹782 Cr | ₹0 Cr |
| CWIP | ₹305 Cr ▲90.6% | ₹160 Cr ▼57.2% | ₹374 Cr ▲173.0% | ₹137 Cr ▲34.3% | ₹102 Cr ▼45.5% | ₹187 Cr | ₹0 Cr |
| Investments | ₹194 Cr ▲3.7% | ₹187 Cr ▲142.9% | ₹77 Cr ▼28.0% | ₹107 Cr ▲23.0% | ₹87 Cr ▲171.9% | ₹32 Cr | ₹0 Cr |
| Other Assets | ₹1.5K Cr ▲3.8% | ₹1.4K Cr ▲6.4% | ₹1.3K Cr ▲1.1% | ₹1.3K Cr ▲15.5% | ₹1.1K Cr ▲8.9% | ₹1.0K Cr | ₹0 Cr |
| Total Assets | ₹3.5K Cr ▲6.6% | ₹3.3K Cr ▲12.4% | ₹2.9K Cr ▲12.5% | ₹2.6K Cr ▲15.1% | ₹2.2K Cr ▲10.0% | ₹2.0K Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Operating CF | ₹262 Cr ▼21.1% | ₹332 Cr ▲53.7% | ₹216 Cr ▼13.6% | ₹250 Cr ▲668.2% | ₹-44 Cr | ₹0 Cr |
| Investing CF | ₹-431 Cr ▼4.1% | ₹-414 Cr ▼92.6% | ₹-215 Cr ▼36.1% | ₹-158 Cr ▼13.7% | ₹-139 Cr | ₹0 Cr |
| Financing CF | ₹171 Cr ▲163.1% | ₹65 Cr ▲550.0% | ₹10 Cr ▲106.1% | ₹-163 Cr ▼162.7% | ₹260 Cr | ₹0 Cr |
| Net Cash Flow | ₹2 Cr ▲111.8% | ₹-17 Cr ▼241.7% | ₹12 Cr ▲116.9% | ₹-71 Cr ▼191.0% | ₹78 Cr | ₹0 Cr |
| Free Cash Flow | ₹-186 Cr ▼66.1% | ₹-112 Cr ▼722.2% | ₹18 Cr ▼86.2% | ₹130 Cr ▲170.3% | ₹-185 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 117d ▲18.2% | 99d ▼2.9% | 102d ▲21.4% | 84d ▼27.0% | 115d | — |
| Inventory Days | 280d ▲47.4% | 190d ▼17.4% | 230d ▲22.3% | 188d ▼30.9% | 272d | — |
| Days Payable | 146d ▲62.2% | 90d ▼33.3% | 135d ▲27.4% | 106d ▼13.8% | 123d | — |
| Cash Conv. Cycle | 251d ▲25.5% | 200d ▲1.5% | 197d ▲18.7% | 166d ▼37.1% | 264d | — |
| Working Capital Days | 90d ▼14.3% | 105d ▼4.5% | 110d ▲17.0% | 94d ▼15.3% | 111d | — |
| ROCE | 11.0% ▼35.3% | 17.0% ▲0.0% | 17.0% ▲6.3% | 16.0% ▼15.8% | 19.0% | — |
Source: Screener.in · Lower days = better efficiency
About Aarti Pharmalabs Limited
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Aarti Pharmalabs Limited share price today?▾
Aarti Pharmalabs Limited (AARTIPHARM) is currently trading at ₹702.35 on NSE, up 0.63% as of the last market session. Prices update daily after market close on MarketNetra.
Is Aarti Pharmalabs Limited available in F&O (Futures & Options)?▾
Yes, Aarti Pharmalabs Limited (AARTIPHARM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Aarti Pharmalabs Limited 52-week high and low?▾
Aarti Pharmalabs Limited's 52-week high is ₹970 and the 52-week low is ₹584. The current price of ₹702.35 is 27.6% below the 52W high.
What is Aarti Pharmalabs Limited P/E ratio?▾
Aarti Pharmalabs Limited's current P/E ratio is 36.3. This indicates the market is paying ₹36.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Aarti Pharmalabs Limited options?▾
Aarti Pharmalabs Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AARTIPHARM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.